In Vitro and In Vivo Radiotoxicity and Biodistribution of Thallium-201 Delivered to Cancer Cells by Prussian Blue Nanoparticles

被引:0
|
作者
Wulfmeier, Katarzyna M. [1 ]
Pellico, Juan [1 ,2 ]
Machado, Pedro [3 ,4 ]
Carbajal, M. Alejandra [3 ]
Bakker, Saskia E. [5 ]
de Rosales, Rafael T. M. [1 ]
Sunassee, Kavitha [1 ]
Blower, Philip J. [1 ]
Abbate, Vincenzo [6 ]
Terry, Samantha Y. A. [1 ]
机构
[1] Kings Coll London, Sch Biomed Engn & Imaging Sci, London SE1 7EH, England
[2] CSIC, Inst Mat Sci Barcelona ICMAB, Bellaterra 08193, Spain
[3] Kings Coll London, Ctr Ultrastruct Imaging, London SE1 9RT, England
[4] Oxford Instruments Nanoanal, High Wycombe HP12 3SE, England
[5] Univ Warwick, Adv Bioimaging, Coventry CV4 7AL, England
[6] Kings Coll London, Inst Pharmaceut Sci, London SE1 9NH, England
基金
英国惠康基金; 英国工程与自然科学研究理事会;
关键词
Tl-201; Prussian blue nanoparticles; thallium binding; targeted radionuclide therapy; Auger electron-emitters; THERAPY; PRINCIPLES; ANALOGS; SHAPE; SIZE;
D O I
10.1021/acsami.4c21700
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Thallium-201 (t(1/2) = 73 h) emits around 37 Auger and other secondary electrons per decay and is highly radiotoxic when internalized into cancer cells. However, the lack of effective chelators hinders its application in molecular radiotherapy. This study evaluates Prussian blue nanoparticles, coated with citric acid (Tl-201-caPBNPs) or chitosan (Tl-201-chPBNPs), as a Tl-201 delivery vehicle compared with unbound Tl-201(+). Cellular uptake and efflux kinetics and radiotoxicity using clonogenic and gamma H2AX DNA damage assays were evaluated in vitro for both nanoparticle types. Subcellular localization was also assessed using electron microscopy with energy-dispersive X-ray spectroscopy. Biodistribution of Tl-201-chPBNPs was evaluated in vivo in mice bearing subcutaneous A549 tumor xenografts, using single photon computed tomography imaging and ex vivo tissue counting. Compared with unbound Tl-201(+), Tl-201-chPBNPs showed higher cellular uptake, while Tl-201-caPBNP uptake was reduced. Both showed delayed efflux of Tl-201 from cancer cells. PBNPs prelocalized within cells enhanced the capture and retention of Tl-201(+) ions. Both types of PBNPs accumulated in cytoplasmic vesicular compartments and were not visible in the nuclei. Furthermore, Tl-201-radiolabeled chPBNPs but not Tl-201-caPBNPs showed significantly greater radiotoxicity than unbound Tl-201(+) per Becquerel of radiotoxicity provided in media, resulting from their higher uptake and delayed efflux. However, when corrected for the greater activity accumulated in cells and delayed efflux, the radiotoxicity of Tl-201-chPBNPs was lower than that of unbound Tl-201(+), possibly due to differences in subcellular localization. These findings highlight the potential of chPBNPs for enhancing the uptake and retention of Tl-201 in cancer cells and development of targeted radionuclide therapy.
引用
收藏
页码:13577 / 13591
页数:15
相关论文
共 50 条
  • [1] The cellular uptake of thallium-201 (201Tl) delivered by Prussian blue nanoparticles is mapped at the subcellular level in lung cancer cells
    Wulfmeier, Katarzyna
    Pellico, Juan
    Machado, Pedro
    Carbajal, Alejandra
    Bakker, Saskia
    Blower, Philip
    Abbate, Vincenzo
    Terry, Samantha
    BIOPHYSICAL JOURNAL, 2024, 123 (03) : 450A - 450A
  • [2] Mechanisms of inclusion of thallium-201 into Prussian blue nanoparticles for nuclear medicine applications
    Wulfmeier, Katarzyna M.
    Blower, Philip J.
    Fajardo, Galo Paez
    Huband, Steven
    de Rosales, Rafael T. M.
    Walker, David
    Terry, Samantha Y. A.
    Abbate, Vincenzo
    Pellico, Juan
    JOURNAL OF MATERIALS CHEMISTRY B, 2024, 12 (33) : 8087 - 8098
  • [3] In vitro proof of concept studies of radiotoxicity from Auger electron-emitter thallium-201
    Osytek, Katarzyna M.
    Blower, Philip J.
    Costa, Ines M.
    Smith, Gareth E.
    Abbate, Vincenzo
    Terry, Samantha Y. A.
    EJNMMI RESEARCH, 2021, 11 (01)
  • [4] In vitro proof of concept studies of radiotoxicity from Auger electron-emitter thallium-201
    Katarzyna M. Osytek
    Philip J. Blower
    Ines M. Costa
    Gareth E. Smith
    Vincenzo Abbate
    Samantha Y. A. Terry
    EJNMMI Research, 11
  • [5] Thallium-201 (201Tl) - Labelled Prussian Blue Nanoparticles for Auger-Meitner Electron-Emitter Radionuclide Therapy
    Osytek, K.
    Pellico, J.
    Blower, P.
    Terry, S.
    Abbate, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S651 - S651
  • [6] Biosafety and biocompatibility assessment of Prussian blue nanoparticles in vitro and in vivo
    Wang, Zhou
    Long, Ying
    Fan, Jialong
    Xiao, Chang
    Tong, Chunyi
    Guo, Chenglin
    Chen, Xinyi
    Liu, Bin
    Yang, Xiaoping
    NANOMEDICINE, 2020, 15 (27) : 2655 - 2670
  • [7] Auger Electron Emitter Radionuclide Therapy: In vitro Study of Thallium-201 Kinetics and Toxicity in Breast and Prostate Cancer Cells
    Osytek, K.
    Costa, I.
    Verger, E.
    Al-Salemee, F.
    Cheng, J.
    Terry, S.
    Abbate, V.
    Blower, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S77 - S78
  • [8] In vitro and in vivo removal efficacy of insoluble Prussian blue in combination with calcium polystyrene sulfonate for thallium
    Jain, Shelly
    Kumar, Vivek
    Koul, Ashwani
    Singh, Ajay Kumar
    Sandal, Nidhi
    BIOMETALS, 2023, 36 (05) : 1125 - 1140
  • [9] In vitro and in vivo removal efficacy of insoluble Prussian blue in combination with calcium polystyrene sulfonate for thallium
    Shelly Jain
    Vivek Kumar
    Ashwani Koul
    Ajay Kumar Singh
    Nidhi Sandal
    BioMetals, 2023, 36 : 1125 - 1140
  • [10] Prussian blue nanoparticles as nanocargoes for delivering DNA drugs to cancer cells
    Wang, Shao-Jen
    Chen, Chun-Sheng
    Chen, Lin-Chi
    SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS, 2013, 14 (04)